NORWOOD ABBEY LIMITED(NAL)

name changed to Sino-Excel Energy Limited

all resolutions as per the Notice of Annual General Meeting were passed on a show of hands at the Annual General Meeting of shareholders held today at 2.30 pm

the following reports were lodged with ASX on 29 th April 2011: 1) December 2008 Half Yearly report 2) 2009 Annual Report 3) December 2009 Half Yearly report 4) 2010 Annual Report 5) December 2010 Half yearly report 6) Letter to shareholders 7) Notice of Annual General Meeting / Explanatory Memorandum / Independent Experts Report 8) Appendix 3B 9) ASX Waiver from Listing Rule 7.3.2 10) Prospectus

lodges a prospectus for the issue of: (i) up to 14,705,882 Shares (full subscription) at an issue price of 51 cents per Share to raise a minimum of A$2.5 million and up to A$7.5 million (Public Offer); (ii) 117,647,059 Shares to the Vendor Parties of Sino-Excel Energy Pte Ltd (Vendor Offer); and (iii) 3,090,183 Shares to specified creditors of the Company (Creditor Offer)

the Company is undertaking a public share offer at 51 cents (post the proposed 30:1 share consolidation) per Share to raise a minimum of $2.5 million and up to $7.5 million (Capital Raising). The primary purpose of the Capital Raising is to raise working capital for the Company going forward and to demonstrate sufficient spread requirements to enable the Company to apply for re-quotation of its securities on ASX following completion of the Sino-Excel Acquisition

the Company has previously advised that Sino-Excel Energy Pte Ltd (formerly Sino-Excel Petroleum Holdings Pte Ltd) ["Sino-Excel"] is to list through a merger and share exchange with Norwood Abbey Ltd. As shareholders are already aware, the due diligence process has extended for a much longer period that expected. The delays have been unavoidable and derive from the need for a range of structural matters having to be addressed at the Chinese level. To this end, due diligence has been considerably more involved than a local transaction. The company is now pleased to confirm that a final draft of the Chinese legal due diligence has been received. Further, the audits of the Chinese operating entity have also been completed and released to Norwood. Accordingly, preparation of the Independent Expert's Report (IER) and Investigating Accountant's Report (IAR) are now proceeding

issues 60,893,082 fully paid shares to creditors

the company has negotiated an extension of the convertible loan from Lettered Management Pty Ltd to December 31 2010. The loan will be interest free and will convert automatically upon a completion of the proposed Sino-Excel deal - the company has also raised $250,000 through an additional converting note issue. The notes expire on October 27 2010

company advises that it has entered into a Settlement Deed with major creditor TER in accordance with parameters previously provided for in the accounts, in a mix of cash and shares - the proceedings initiated by TER have been discontinued - all liabilities will be extinguished subject to the company issuing the share component at the earlier of the completion of the China coal transaction or February 26 2010

Norwood Abbey Ltd [ASX:NAL] is pleased to announce that it has entered into a binding Letter of Intent ("LOI") with Sino-Excel Petroleum Holdings Pte Ltd ("Sino-Excel") and DeBang Resources Ltd ("DB") under which Norwood will acquire a 100% interest in Sino-Excel

releases Preliminary Final Report

company advises that Norwood Immunology Ltd's ("NIM") half year report has been lodged and is posted on the NIM website

the company advises that Norwood Immunology Ltd has now completed the transaction to sell its equity in Bestiwil Holdings NV and subsidiary Virosome Biologicals NV

company confirms that its merger plans are continuing to progress - the merger candidate is currently dealing with certain internal issues for which resolution is required prior to a final agreement with Norwood - the company is working towards completion of its half-yearly accounts, which are being impacted by the merger plans

Norwood Abbey Ltd (ASX:NAL) advises that the 21%-owned Norwood Immunology has signed an agreement with NASDAQ-listed Mymetics Inc for the sale of Bestiwil. Bestiwil is the parent entity of the group holding NIM's Virosome assets

securities suspended from quotation following failure to lodge financial reports for the period ended 31 December 2008

the suspension of trading in the securities of Norwood Abbey Limited (the "Company") will be lifted before the commencement of trading on Monday, 6 October 2008 in accordance with listing rule 17.8, following receipt of the Company's annual report for the year ended 30 June 2008

securities suspended from quotation following failure to lodge financial statements for the period to 30 June 2008

securities reinstated to quotation

securities suspended from quotation following failure to lodge financial statements for the period to 30 June 2007

shares reinstated to quotation

securities suspended from quotation because of failure to lodge full year accounts for the period to 30 June 2006